Clari Vest Asset Management LLC Ultragenyx Pharmaceutical Inc. Transaction History

Clari Vest Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$73.71 - $87.86 $1.98 Million - $2.36 Million	-26,908 Closed	0 $0
Q3 2021 Nov 08, 2021	SELL	$77.92 - $102.4 $467,753 - $614,707	-6,003 Reduced 18.24%	26,908 $2.43 Million
Q2 2021 Aug 09, 2021	SELL	$92.19 - $115.71 $16,686 - $20,943	-181 Reduced 0.55%	32,911 $3.14 Million
Q1 2021 May 13, 2021	BUY	$106.9 - $167.73 $291,516 - $457,399	2,727 Added 8.98%	33,092 $3.77 Million
Q4 2020 Feb 09, 2021	SELL	$84.4 - $177.39 $744,661 - $1.57 Million	-8,823 Reduced 22.51%	30,365 $4.2 Million
Q3 2020 Nov 09, 2020	BUY	$72.98 - $90.0 $2.86 Million - $3.53 Million	39,188 New	39,188 $3.22 Million

325

85.5M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.14B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Clari Vest Asset Management LLC with notifications on news.